-
Scientists successfully treated a rare disease with the experimental gene-editing technique. It could open the door to new ways of treating more common disorders in the future.
-
The unprecedented study involves using the gene-editing technique CRISPR to edit a gene while it's still inside a patient's body. In exclusive interviews, NPR talks with two of the first participants.
-
French scientist Emmanuelle Charpentier and American Jennifer A. Doudna have won the Nobel Prize in chemistry for developing a method of genome editing known as CRISPR.
-
The 2020 Nobel Prize in chemistry was awarded for research into "rewriting the code of life." Emmanuelle Charpentier of France and Jennifer Doudna of the U.S. are the laureates.
-
Since receiving a landmark treatment with the gene-editing tool CRISPR, a sickle cell patient has the strength to care for herself and her children — while navigating the pandemic.
-
A new technique uses the CRISPR molecule to snip away at the part of RNA viruses that allows them to spread infection by making copies of themselves.
-
NPR visited the only lab in the world known to be trying to use the powerful gene-editing tool CRISPR to modify the DNA in human sperm. If successful, it could be used to prevent genetic disorders.
-
Victoria Gray, 34, of Forest, Miss., has sickle cell disease. She is the first patient ever to be publicly identified as being involved in a study testing the use of CRISPR for a genetic disease.
-
Superbugs are bacteria that can beat modern medicine's most powerful drugs. So doctors are racing to find new ways to fight back.
-
This could be a crucial year for the powerful gene-editing technique CRISPR as researchers start testing it in patients to treat diseases such as cancer, blindness and sickle cell disease.